Detection of PERV by polymerase chain reaction and its safety in bioartificial liver support system

World Journal of Gastroenterology

Volumn 12, Issue 8, 2006, Pages 1287-1291

  Wang, Hai Hui ^a   Wang, Ying Jie ^a   Liu, Hong Ling ^a   Liu, Jun ^a   Huang, Yan Ping ^a   Gou, Hai Tao ^a   Wang, Yu Ming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bioartificial liver support systems; PERV; Polymerase chain reaction

Indexed keywords

MITOGENIC AGENT; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOARTIFICIAL LIVER; BIOREACTOR; BLOOD SAMPLING; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; DNA SEQUENCE; FETUS LIVER; HEMOPERFUSION; HUMAN; IN VITRO STUDY; LIVER CELL; LIVER SUPPORT; MEMBRANE PERMEABILITY; NONHUMAN; POLYMERASE CHAIN REACTION; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SAFETY; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SWINE; VIRUS DETECTION; VIRUS INFECTION;

EID: 33645520832     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i8.1287     Document Type: Article

References (45)

1. Nyberg SL, Peshwa MV, Payne WD, Hu WS, Cerra FB. Evolution of the bioartificial liver: the need for randomized clinical trials. Am J Surg 1993; 166: 512-521
2. Sechser A, Osorio J, Freise C, Osorio RW. Artificial liver support devices for fulminant liver failure. Clin Liver Dis 2001; 5: 415-430
3. Li JG, Chen YK. Progress of cells in bioartificial liver. Shijie Huaren Xiaohua Zazhi 2002; 10: 699-701
4. Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997; 3: 282-286
5. Tsiaoussis J, Newsome PN, Nelson LJ, Hayes PC, Plevris JN. Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transpl 2001; 7: 2-10
6. Boudjema K, Bachellier P, Wolf P, Tempe JD, Jaeck D. Auxiliary liver transplantation and bioartificial bridging procedures in treatment of acute liver failure. World J Surg 2002; 26: 264-274
7. Bismuth H, Figueiro J, Samuel D. What should we expect from a bioartificial liver in fulminant hepatic failure? Artif Organs 1998; 22: 26-31
8. Weiss RA. Xenografts and retroviruses. Science 1999; 285: 1221-1222
9. Birmingham K. FDA subcommittee finds no evidence of PERV transmission. Nat Med 1999; 5: 855
10. Tacke SJ, Kurth R, Denner J. Porcine endogenous retroviruses inhibit human immune cell function: risk for xenotransplantation? Virology 2000; 268: 87-93
11. Akiyoshi DE, Denaro M, Zhu H, Greenstein JL, Banerjee P, Fishman JA. Identification of a full-length cDNA for an endogenous retrovirus of miniature swine. J Virol 1998; 72: 4503-4507
12. Wilson CA, Wong S, Muller J, Davidson CE, Rose TM, Burd P. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol 1998; 72: 3082-3087
13. Tacke S, Specke V, Stephan O, Seibold E, Bodusch K, Denner J. Porcine endogenous retroviruses: diagnostic assays and evidence for immunosuppressive properties. Transplant Proc 2000; 32: 1166
14. Tacke SJ, Kurth R, Denner J. Porcine endogenous retroviruses inhibit human immune cell function: risk for xenotransplantation? Virology 2000; 268: 87-93
15. Seglen PO. Preparation of rat liver cells. II. Effects of ions and chelators on tissue dispersion. Exp Cell Res 1973; 76: 25-30
16. Specke V, Tacke SJ, Boller K, Schwendemann J, Denner J. Porcine endogenous retroviruses: in vitro host range and attempts to establish small animal models. J Gen Virol 2001; 82: 837-844
17. Martin U, Steinhoff G, Kiessig V, Chikobava M, Anssar M, Morschheuser T, Lapin B, Haverich A. Porcine endogenous retrovirus (PERV) was not transmitted from transplanted porcine endothelial cells to baboons in vivo. Transpl Int 1998; 11: 247-251
18. Specke V, Plesker R, Coulibaly C, Boller K, Denner J. Productive infection of a mink cell line with porcine endogenous retroviruses (PERVs) but lack of transmission to minks in vivo. Arch Virol 2002; 147: 305-319
19. Ericsson T, Oldmixon B, Blomberg J, Rosa M, Patience C, Andersson G. Identification of novel porcine endogenous betaretrovirus sequences in miniature swine. J Virol 2001; 75: 2765-2770
20. Wang YJ, Liu GD, Liu J, Li MD. Large-scale isolation of suckling pig hepatocytes. Shijie Huaren Xiaohua Zazhi 1999; 7: 661-662
21. Gill RQ, Sterling RK. Acute liver failure. J Clin Gastroenterol 2001; 33: 191-198
22. Ash SR. Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites. Artif Organs 1994; 18: 355-362
23. Chenard-Neu MP, Boudjema K, Bernuau J, Degott C, Belghiti J, Cherqui D, Costes V, Domergue J, Durand F, Erhard J, De Hemptinne B, Gubernatis G, Hadengue A, Kemnitz J, McCarthy M, Maschek H, Mentha G, Oldhafer K, Portmann B, Praet M, Ringers J, Rogiers X, Rubbia L, Schalm S, Bellocq JP. Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure - a multicenter European study. Hepatology 1996; 23: 1119-1127
24. Chen Z, Ding YT, Zhang HY. Serum-free medium for culture of suckling pig hepatocytes. Shijie Huaren Xiaohua Zazhi 2002; 10: 320-323
25. Tsiaoussis J, Newsome PN, Nelson LJ, Hayes PC, Plevris JN. Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transpl 2001; 7: 2-10
26. Boudjema K, Bachellier P, Wolf P, Tempe JD, Jaeck D. Auxiliary liver transplantation and bioartificial bridging procedures in treatment of acute liver failure. World J Surg 2002; 26: 264-274
27. Bain VG, Montero JL, de La Mata M. Bioartificial liver support. Can J Gastroenterol 2001; 15: 313-318
28. Martin U, Kiessig V, Blusch JH, Haverich A, von der Helm K, Herden T, Steinhoff G. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet 1998; 352: 692-694
29. van der Laan LJ, Lockey C, Griffeth BC, Frasier FS, Wilson CA, Onions DE, Hering BJ, Long Z, Otto E, Torbett BE, Salomon DR. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature 2000; 407: 90-94
30. Paradis K, Langford G, Long Z, Heneine W, Sandstrom P, Switzer WM, Chapman LE, Lockey C, Onions D, Otto E. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science 1999; 285: 1236-1241
31. Denner J, Specke V, Schwendemann J, Tacke SJ. Porcine endogenous retroviruses (PERVs): adaptation to human cells and attempts to infect small animals and non-human primates. Ann Transplant 2001; 6: 25-33
32. Denner J, Specke V, Thiesen U, Karlas A, Kurth R. Genetic alterations of the long terminal repeat of an ecotropic porcine endogenous retrovirus during passage in human cells. Virology 2003; 314: 125-133
33. Irgang M, Sauer IM, Karlas A, Zeilinger K, Gerlach JC, Kurth R, Neuhaus P, Denner J. Porcine endogenous retroviruses: no infection in patients treated with a bioreactor based on porcine liver cells. J Clin Virol 2003; 28: 141-154
34. Nyberg SL, Hibbs JR, Hardin JA, Germer JJ, Persing DH. Transfer of porcine endogenous retrovirus across hollow fiber membranes: significance to a bioartificial liver. Transplantation 1999; 67: 1251-1255
35. Deng YM, Tuch BE, Rawlinson WD. Transmission of porcine endogenous retroviruses in severe combined immunodeficient mice xenotransplanted with fetal porcine pancreatic cells. Transplantation 2000; 70: 1010-1016
36. Kuddus R, Patzer JF 2nd, Lopez R, Mazariegos GV, Meighen B, Kramer DJ, Rao AS. Clinical and laboratory evaluation of the safety of a bioartificial liver assist device for potential transmission of porcine endogenous retrovirus. Transplantation 2002; 73: 420-429
37. Clemenceau B, Jegou D, Martignat L, Sai P. Microchimerism and transmission of porcine endogenous retrovirus from a pig cell line or specific pathogen-free pig islets to mouse tissues and human cells during xenografts in nude mice. Diabetologia 2002; 45: 914-923
38. Specke V, Schuurman HJ, Plesker R, Coulibaly C, Ozel M, Langford G, Kurth R, Denner J. Virus safety in xenotransplantation: first exploratory in vivo studies in small laboratory animals and non-human primates. Transpl Immunol 2002; 9: 281-288
39. Argaw T, Ritzhaupt A, Wilson CA. Development of a real time quantitative PCR assay for detection of porcine endogenous retrovirus. J Virol Methods 2002; 106: 97-106
40. Blusch JH, Patience C, Takeuchi Y, Templin C, Roos C, Von Der Helm K, Steinhoff G, Martin U. Infection of nonhuman primate cells by pig endogenous retrovirus. J Virol 2000; 74: 7687-7690
41. Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johann M, Azoulay D, Ducot B, Chiche L. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 1995; 222: 109-119
42. Hu HZ, Xu XP, Gao Y and Yang JZ. Experimental study of treatment of acute liver failure with bioartificial liver in pigs. Shijie Huaren Xiaohua Zazhi 2001; 9: 139-143
43. Riordan SM, Williams R. Extracorporeal support and hepatocyte transplantation in acute liver failure and cirrhosis. J Gastroenterol Hepatol 1999; 14: 757-770
44. Morsiani E, Pazzi P, Puviani AC, Brogli M, Valieri L, Gorini P, Scoletta P, Marangoni E, Ragazzi R, Azzena G, Frazzoli E, Di Luca D, Cassai E, Lombardi G, Cavallari A, Faenza S, Pasetto A, Girardis M, Jovine E, Pinna AD. Early experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients. Int J Artif Organs 2002; 25: 192-202
45. Pitkin Z, Mullon C. Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system. Artif Organs 1999; 23: 829-833